(Q44538019)

3 December 2017

0 references

Vaccine adjuvant safety: the elephant in the room (English)

1 reference

3 December 2017

1

1 reference

3 December 2017

publication date

1 July 2013

1 reference

Expert Review of Vaccines

3 December 2017

published in

1 reference

3 December 2017

volume

12

1 reference

3 December 2017

issue

7

1 reference

3 December 2017

page(s)

715-717

1 reference

Vaccine adjuvants: current state and future trends

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

Approaching the asymptote? Evolution and revolution in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

The danger model: a renewed sense of self

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

THE COURSE OF EXPERIMENTAL AUTOALLERGIC THYROIDITIS IN INBRED GUINEA PIGS. THE PATHOLOGIC CHANGES AND THEIR RELATIONSHIP TO THE IMMUNE RESPONSE OVER A 2 YEAR PERIOD

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Française contre les Myopathies (AFM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

Freeing vaccine adjuvants from dangerous immunological dogma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.811198

10.1586/14760584.2013.811198

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference